TR200201128T2 - PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. - Google Patents

PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.

Info

Publication number
TR200201128T2
TR200201128T2 TR2002/01128T TR200201128T TR200201128T2 TR 200201128 T2 TR200201128 T2 TR 200201128T2 TR 2002/01128 T TR2002/01128 T TR 2002/01128T TR 200201128 T TR200201128 T TR 200201128T TR 200201128 T2 TR200201128 T2 TR 200201128T2
Authority
TR
Turkey
Prior art keywords
tetrahydrothiopyraniphalazinone
derivatives
pde4 inhibitors
formula
inhibitors
Prior art date
Application number
TR2002/01128T
Other languages
English (en)
Inventor
Hatzelmann Armin
Bundschuh Daniela
Kley Hans-Peter
Jan Sterk Geert
Johanna Van Der Laan Ivonne
Timmermann Hendrik
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of TR200201128T2 publication Critical patent/TR200201128T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Içerisindeki R1, R2, A ve Ar' nin, tarifnamede verildigi üzere anlamlari tasidigi formül (I)' deki bilesikler; yeni etkili PDE4 inhibitörleridir. FORMÜL (I)
TR2002/01128T 1999-10-25 2000-10-24 PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. TR200201128T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99121243 1999-10-25
US20395000P 2000-05-12 2000-05-12

Publications (1)

Publication Number Publication Date
TR200201128T2 true TR200201128T2 (tr) 2002-08-21

Family

ID=26153155

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01128T TR200201128T2 (tr) 1999-10-25 2000-10-24 PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.

Country Status (20)

Country Link
US (2) US6544993B1 (tr)
EP (1) EP1244654A1 (tr)
JP (1) JP2003512466A (tr)
KR (1) KR20020043238A (tr)
CN (1) CN1146562C (tr)
AU (1) AU781137B2 (tr)
BR (1) BR0014990A (tr)
CA (1) CA2388119A1 (tr)
CZ (1) CZ20021457A3 (tr)
EA (1) EA005856B1 (tr)
HK (1) HK1047276A1 (tr)
HR (1) HRP20020350A2 (tr)
HU (1) HUP0203487A2 (tr)
IL (1) IL148807A0 (tr)
MX (1) MXPA02003581A (tr)
NO (1) NO20021959L (tr)
PL (1) PL354979A1 (tr)
SK (1) SK7232002A3 (tr)
TR (1) TR200201128T2 (tr)
WO (1) WO2001030777A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781137B2 (en) * 1999-10-25 2005-05-05 Altana Pharma Ag Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors
NZ527424A (en) * 2001-02-15 2005-02-25 Altana Pharma Ag Phthalayinone-piperidino-derivatives as PDE4 inhibitors
BR0209076A (pt) * 2001-04-25 2004-08-10 Altana Pharma Ag Derivados de piperazino e seu uso como inibidor de pde4
EP1385848A2 (en) * 2001-04-25 2004-02-04 ALTANA Pharma AG Phtalazinones derivatives useful as pde4/7 inhibitors
TWI347845B (en) * 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
US20060167001A1 (en) * 2002-08-10 2006-07-27 Sterk Jan G Pyridazinone-derivatives as pde4 inhibitors
WO2004018449A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
US20060166995A1 (en) * 2002-08-10 2006-07-27 Altana Pharma Ag Piperidine-n-oxide-derivatives
HRP20050198A2 (hr) * 2002-08-10 2006-04-30 Altana Pharma Ag Piperidin-piridazoni i ftalazoni kao inhibitori pde4
PL378247A1 (pl) * 2003-01-14 2006-03-20 Altana Pharma Ag Inhibitory PDE4 w terapii nowotworów komórek limfoidalnych
US20080227790A1 (en) * 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
EP1716133B1 (en) * 2004-02-04 2008-03-26 Nycomed GmbH 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
PL2589599T4 (pl) * 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
PL2651417T3 (pl) * 2010-12-16 2017-08-31 Calchan Limited Pochodne pirolopirymidyny hamujące ASK1
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP2968323A4 (en) 2013-03-13 2016-12-14 Flatley Discovery Lab PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
DK0672031T3 (da) 1992-12-02 2003-06-10 Pfizer Catecholdiethere som selektive PDE IV-inhibitorer
DE19533975A1 (de) 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
SK283270B6 (sk) 1997-01-15 2003-04-01 Altana Pharma Ag Ftalazinóny, farmaceutické prostriedky s ich obsahom a ich použitie
US6380196B1 (en) 1997-12-15 2002-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Dihydrobenzofurans
AU1760399A (en) 1997-12-15 1999-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh New phthalazinones
SI1070056T1 (en) 1998-03-14 2004-12-31 Altana Pharma Ag Phthalazinone pde iii/iv inhibitors
AU781137B2 (en) * 1999-10-25 2005-05-05 Altana Pharma Ag Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors

Also Published As

Publication number Publication date
IL148807A0 (en) 2002-09-12
HK1047276A1 (zh) 2003-02-14
MXPA02003581A (es) 2002-10-23
PL354979A1 (en) 2004-03-22
SK7232002A3 (en) 2002-09-10
AU781137B2 (en) 2005-05-05
WO2001030777A1 (en) 2001-05-03
NO20021959D0 (no) 2002-04-25
NO20021959L (no) 2002-05-29
US6846821B2 (en) 2005-01-25
BR0014990A (pt) 2002-06-18
US6544993B1 (en) 2003-04-08
CZ20021457A3 (cs) 2002-07-17
CN1382137A (zh) 2002-11-27
CA2388119A1 (en) 2001-05-03
HUP0203487A2 (hu) 2003-02-28
AU1515101A (en) 2001-05-08
JP2003512466A (ja) 2003-04-02
EA200200381A1 (ru) 2002-10-31
CN1146562C (zh) 2004-04-21
US20030166655A1 (en) 2003-09-04
EA005856B1 (ru) 2005-06-30
KR20020043238A (ko) 2002-06-08
EP1244654A1 (en) 2002-10-02
HRP20020350A2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
GB9929552D0 (en) Compounds
DE60012188D1 (de) Fungizide
TR199901653T2 (tr) Fitalazinonlar.
DK0931788T3 (da) Metalloproteasehæmmere
AU5414000A (en) Compounds
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SE0004245D0 (sv) Novel compounds and their use
GB0114185D0 (en) Compounds
ATE258930T1 (de) Dihydrobenzifurane
HK1047276A1 (zh) 作为pde4抑制剂的四氢噻喃2，3-二氮杂萘酮类衍生物
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
SE9903290D0 (sv) Novel compounds
DK1204659T3 (da) Serotonerge benzofuraner
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ATE287403T1 (de) 6-phenylbenzonaphthyidine
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
DK1244643T3 (da) Tryptaseinhibitorer
DK1244614T3 (da) Tryptase-inhibitorer
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE60216920D1 (en) Tryptase-inhibitoren
AU758194C (en) Novel benzimidazoles and benzoxazoles
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.